Tang Capital Management LLC Uro Gen Pharma Ltd. Transaction History
Tang Capital Management LLC
- $1.67 Billion
- Q2 2025
A detailed history of Tang Capital Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Tang Capital Management LLC holds 1,000,000 shares of URGN stock, worth $19.2 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$19.2 Million% of portfolio
0.82%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
158Shares Held
39.6MCall Options Held
2.02MPut Options Held
702K-
Rtw Investments, LP New York, NY4.54MShares$87.2 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$61.3 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$47.6 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$42.2 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$42.1 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $437M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...